Project 3 - Ex vivo immune profiling of dengue viruses and vaccines

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Icahn School of Medicine At Mount Sinai
Country	United States
Start Date	Feb 11, 2021
End Date	May 31, 2022
Duration	474 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10330073`

Grant Description

The COVID-19 pandemic is the most important health challenge to the US population within a century.

Most epidemiological data have focused on cases that resulted in severe respiratory disease seen predominantly in adults.

Inadequate information regarding the infection burden in children is available, especially in the context of households that are prospectively monitored with repetitive testing. This information is critical to determine the silent and symptomatic infection rate in children. The NIAID-supported Human Epidemiology and Response to SARS- CoV-2 (HEROS) survey study is designed to fill this gap.